Alternatives to Aummune

Biotechnology company developing cell and gene therapies for serious diseases.

AI-powered blood test for early cancer detection and subtyping.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

AI-driven digital twin of embryo development for cell-based therapies.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Compressing biology to develop the next generation of therapies.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Developing a novel immune cell-based delivery platform for intracellular therapeutic protein transfer.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Drug development company creating first-in-class RNA-targeting therapeutics using a proprietary platform.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Developing novel therapeutics for rare genetic diseases.

MyBiotics Pharma develops innovative microbiome-based pharmabiotics and drugs using proprietary bacterial mixes and efficient delivery technologies.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Biopharmaceutical startup developing novel therapies for rare genetic diseases.

AI-driven platform for protein-level disease mapping and drug discovery.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Biotechnology company developing novel therapies for multiple myeloma.

Omnix Medical is developing a novel platform for advanced wound care management.

AI-powered insights platform for life sciences and biotech workflows.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Galimedix Therapeutics is a clinical-stage biopharmaceutical company developing novel radiopharmaceuticals for PET imaging.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Cell and gene therapy company developing biological vehicles for CNS delivery.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Developing novel therapeutics targeting the tumor microenvironment for cancer treatment.

Prophet Bio is a biotech startup focused on developing novel therapeutics for neurodegenerative diseases.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

Cloud-based platform for reproducible computational research in life sciences.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Developing polymer-based nanoparticles for targeted gene therapy delivery.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Developing novel nitroxide-based therapeutics to treat inflammatory lung diseases.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

AI-guided drug discovery platform for tissue-targeted medicines.

EU-based company providing personalized medicine solutions for medical practitioners.

DenovAI Biotech leverages AI for de novo protein design, focusing on novel therapeutics and diagnostics.

AI-powered platform for designing novel molecular structures for new medicines.

Developing engineered biologics to harness the immune system for disease treatment.

Bio-pharmaceutical company developing novel, biologically sourced therapies for animal and human health.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.